These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20619716)

  • 1. [Normal tissue tolerance to external beam radiation therapy: the stomach].
    Oberdiac P; Mineur L
    Cancer Radiother; 2010 Jul; 14(4-5):336-9. PubMed ID: 20619716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Normal tissue tolerance to external beam radiation therapy: the vagina].
    Magné N; Chargari C; Pointreau Y; Haie-Meder C
    Cancer Radiother; 2010 Jul; 14(4-5):369-72. PubMed ID: 20418147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial volume tolerance of the liver to radiation.
    Dawson LA; Ten Haken RK
    Semin Radiat Oncol; 2005 Oct; 15(4):279-83. PubMed ID: 16183482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy for intrahepatic malignancies.
    Quick AM; Lo SS; Mayr NA; Kim EY
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1511-21. PubMed ID: 19828012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
    Young JY; Rhee TK; Atassi B; Gates VL; Kulik L; Mulcahy MF; Larson AC; Ryu RK; Sato KT; Lewandowski RJ; Omary RA; Salem R
    J Vasc Interv Radiol; 2007 Nov; 18(11):1375-82. PubMed ID: 18003987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors.
    Chon YE; Seong J; Kim BK; Cha J; Kim SU; Park JY; Ahn SH; Han KH; Chon CY; Shin SK; Kim DY
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1343-51. PubMed ID: 20934268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Normal tissue tolerance to external beam radiation therapy: bone marrow].
    Drouet F; Lagrange JL
    Cancer Radiother; 2010 Jul; 14(4-5):392-404. PubMed ID: 20598617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Normal tissue tolerance to external beam radiation therapy: eye structures].
    Marchand V; Dendale R
    Cancer Radiother; 2010 Jul; 14(4-5):277-83. PubMed ID: 20615743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
    Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tolerance and efficacy of conformal radiotherapy for hepatocellular carcinoma in cirrhotic patients. Results of the French RTF1 phase II trial].
    Mornex F; Girard N; Merle P; Béziat C; Kubas A; Wautot V; Khodri M; Trepo C
    Cancer Radiother; 2005 Nov; 9(6-7):470-6. PubMed ID: 16219480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors.
    Thomas E; Chapet O; Kessler ML; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):571-8. PubMed ID: 15890602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy for unresectable hepatic malignancies.
    Ben-Josef E; Lawrence TS
    Semin Radiat Oncol; 2005 Oct; 15(4):273-8. PubMed ID: 16183481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for gastroduodenal toxicity based on endoscopy following radiotherapy in patients with hepatocellular carcinoma.
    Yoon H; Oh D; Park HC; Kang SW; Han Y; Lim DH; Paik SW
    Strahlenther Onkol; 2013 Jul; 189(7):541-6. PubMed ID: 23703401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
    Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal tissue tolerance dose metrics for radiation therapy of major organs.
    Milano MT; Constine LS; Okunieff P
    Semin Radiat Oncol; 2007 Apr; 17(2):131-40. PubMed ID: 17395043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.
    Lu JJ; Shakespeare TP; Thiagarajan A; Zhang X; Liang L; Tan S
    Laryngoscope; 2005 May; 115(5):806-10. PubMed ID: 15867644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late effects of radiation therapy on the gastrointestinal tract.
    Coia LR; Myerson RJ; Tepper JE
    Int J Radiat Oncol Biol Phys; 1995 Mar; 31(5):1213-36. PubMed ID: 7713784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapolation of normal tissue complication probability for different fractionations in liver irradiation.
    Tai A; Erickson B; Li XA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):283-9. PubMed ID: 19289259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse hepatic events caused by radiotherapy for advanced hepatocellular carcinoma.
    Furuse J; Ishii H; Nagase M; Kawashima M; Ogino T; Yoshino M
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1512-8. PubMed ID: 16174067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.